Xu Cao Selected Research

Xu Cao Research Topics

Disease

41	Neoplasms (Cancer) 01/2022 - 02/2002
18	Osteoarthritis 10/2022 - 06/2006
13	Inflammation (Inflammations) 01/2022 - 08/2013
11	Osteoporosis 11/2021 - 04/2003
8	Pain (Aches) 03/2022 - 10/2011
7	Breast Neoplasms (Breast Cancer) 02/2022 - 04/2003
6	Bone Resorption 11/2021 - 07/2009
5	Fibrosis (Cirrhosis) 01/2021 - 02/2008
5	Cerebral Palsy (Spastic Diplegia) 04/2010 - 12/2008
4	Intervertebral Disc Degeneration 06/2022 - 01/2017
4	Hypoxia (Hypoxemia) 02/2022 - 01/2007
4	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2015
4	Hypersensitivity (Allergy) 01/2020 - 04/2016
4	Camurati-Engelmann Syndrome (Progressive Diaphyseal Dysplasia) 01/2018 - 07/2009
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 05/2018
3	Neuroblastoma 01/2020 - 12/2017
3	Body Weight (Weight, Body) 04/2019 - 01/2014
3	Rheumatoid Arthritis 01/2019 - 06/2006
3	Ischemia 06/2015 - 07/2010
3	Abdominal Aortic Aneurysm 08/2013 - 12/2012
3	Leukemia 08/2006 - 02/2005
2	Disease Progression 03/2022 - 01/2021
2	Osteosarcoma (Osteogenic Sarcoma) 12/2021 - 08/2017
2	Bone Fractures (Bone Fracture) 11/2021 - 12/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2020
2	Atherosclerosis 12/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 08/2019 - 08/2007
2	Vascular Calcification 08/2019 - 06/2014
2	Adenocarcinoma 01/2019 - 05/2005
2	Hyperlipidemias (Hyperlipidemia) 01/2018 - 08/2013
2	Hypertension (High Blood Pressure) 01/2018 - 08/2013
2	Chronic Disease (Chronic Diseases) 01/2018 - 06/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 05/2005
2	Cystic Fibrosis (Mucoviscidosis) 04/2016 - 11/2012
2	Asthma (Bronchial Asthma) 12/2015 - 05/2014
2	Carcinogenesis 05/2014 - 03/2013
2	Hyperglycemia 01/2014 - 08/2013

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2005
9	Pharmaceutical PreparationsIBA 02/2022 - 01/2016
9	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 02/2002
9	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 05/2005
6	Oxygen (Dioxygen)IBA 01/2021 - 07/2010
5	Biological ProductsIBA 01/2022 - 05/2005
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2010
5	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 04/2012
4	Netrin-1IBA 03/2022 - 01/2019
4	Dinoprostone (PGE2)FDA Link 03/2022 - 12/2019
4	Estrogens (Estrogen)FDA Link 11/2021 - 04/2003
4	MicroRNAs (MicroRNA)IBA 09/2020 - 05/2014
4	GlucocorticoidsIBA 01/2020 - 04/2003
4	Smad4 ProteinIBA 09/2006 - 05/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2006
3	AcidsIBA 01/2022 - 01/2014
3	Neutralizing AntibodiesIBA 01/2022 - 01/2017
3	Insulin-Like PeptidesIBA 12/2021 - 06/2013
3	RNA (Ribonucleic Acid)IBA 09/2021 - 02/2005
3	CytokinesIBA 01/2021 - 11/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2015
3	SulfurIBA 01/2021 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 06/2006
3	Becaplermin (PDGF-BB)FDA Link 01/2020 - 11/2014
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019 - 05/2018
3	cathepsin SIBA 10/2018 - 12/2012
3	Dichlorodiphenyldichloroethane (DDD)IBA 01/2018 - 01/2016
3	NestinIBA 06/2014 - 06/2013
3	Small Interfering RNA (siRNA)IBA 11/2009 - 05/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2022 - 11/2019
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2022 - 01/2019
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 12/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2022
2	Acetic Acid (Vinegar)FDA LinkGeneric 01/2022 - 10/2011
2	Neuroprotective AgentsIBA 01/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 01/2020
2	IntegrinsIBA 01/2022 - 01/2017
2	Therapeutic UsesIBA 09/2021 - 12/2014
2	polysulfideIBA 01/2021 - 01/2018
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 10/2018
2	Alanine Transaminase (SGPT)IBA 01/2021 - 08/2013
2	Sepharose (Agarose)IBA 11/2020 - 02/2005
2	Transcription Factors (Transcription Factor)IBA 09/2020 - 03/2013
2	Adenosine Triphosphatases (ATPase)IBA 01/2020 - 12/2018
2	GYY 4137IBA 01/2019 - 10/2018
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2019 - 11/2010
2	LipidsIBA 01/2018 - 02/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 01/2018
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018 - 02/2017
2	LipopolysaccharidesIBA 07/2016 - 10/2012
2	LigandsIBA 04/2016 - 05/2005
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 04/2016 - 11/2012
2	Messenger RNA (mRNA)IBA 03/2016 - 01/2014
2	AllergensIBA 12/2015 - 05/2014
2	Red Fluorescent ProteinIBA 11/2014 - 04/2012
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2014 - 06/2013
2	Estrogen Receptor alphaIBA 11/2009 - 07/2005

Therapy/Procedure

21	Therapeutics 06/2022 - 02/2014
5	Immunotherapy 01/2022 - 07/2018
3	Radiotherapy 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 10/2020 - 11/2014
2	Exercise Therapy (Therapy, Exercise) 10/2009 - 09/2009